Total investment in the field now over $65 million
New York, NY February 11, 2015 — To conclude Ovarian Cancer Research Fund’s 20th anniversary year, $6.453 million has been awarded in scientific research grants for ovarian cancer and program grants to support gynecologic cancer patients. This brings OCRF’s total investment in research and related educational and support initiatives to over $65 million.
The twenty new OCRF research grants have been awarded to top scientists at fourteen leading medical centers across the country. These include: ten Ann Schreiber Mentored Investigator Awards that provide funding for promising young investigators working under the supervision of a mentor who is a recognized leader in the field of ovarian cancer research; seven Liz Tilberis Early Career Awards for scientists establishing their own independent research in ovarian cancer; and three Program Project Development Grants, which fund large ovarian cancer research projects that involve several investigators.
“The quality of the proposals and funded grants continues to increase every year,” says Jeff Boyd, Ph.D., OCRF’s Scientific Advisory Committee Chair and Board Member, and Senior Vice President, Molecular Medicine at Fox Chase Cancer Center. “OCRF has experienced tremendous growth and has made significant progress in the field over the past two decades, and these new grants are a fitting way to commemorate twenty years of outstanding research.”
Ovarian Cancer Research Fund’s national Woman to Woman Program provides outstanding support for women in treatment, their partners, families and other caregivers by pairing gynecologic cancer patients with professionally trained and supervised survivor volunteers who provide one-on-one emotional support and mentoring. OCRF’s new Woman to Woman Program grant recipients are Mercy Medical Center in Baltimore, MD, and Oregon Health and Science University in Portland, OR.
“We are so grateful to our many donors, including those who support us through events like our Super Saturday shopping events and our Ovarian Cycle indoor rides, as well as our generous corporate partners, for enabling us to fund these much-needed grants,” says Audra Moran, President and CEO of Ovarian Cancer Research Fund. “And we are so grateful to QVC for their continued national support of OCRF’s Woman to Woman Program, which has now expanded to serve women with gynecologic cancers and their loved ones at 16 sites in 10 states, with plans to reach more than 20 programs by the end of 2015.”
